These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2833379)

  • 1. X-linked lymphoproliferative disease: a karyotype analysis.
    Harris A; Docherty Z
    Cytogenet Cell Genet; 1988; 47(1-2):92-4. PubMed ID: 2833379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV) and X-linked lymphoproliferative syndrome (XLP).
    Tatsumi E; Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S109-13. PubMed ID: 3030340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked lymphoproliferative syndrome provides clues to the pathogenesis of Epstein-Barr virus-induced lymphomagenesis.
    Purtilo DT; Yasuda N; Grierson HL; Okano M; Brichacek B; Davis J
    Princess Takamatsu Symp; 1987; 18():149-58. PubMed ID: 2852188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [X-chromosome recessive lymphoproliferative disease (XLP): molecular genetic studies].
    Schuster V; Grimm T; Kress W; Seidenspinner S; Belohradsky BH; Müller P; Kreth HW
    Klin Padiatr; 1995; 207(5):271-6. PubMed ID: 7500602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathology of the X-linked lymphoproliferative syndrome.
    Purtilo DT
    Haematol Blood Transfus; 1981; 26():207-14. PubMed ID: 6274747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
    Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus.
    Lanyi A; Li B; Li S; Talmadge CB; Brichacek B; Davis JR; Kozel BA; Trask B; van den Engh G; Uzvolgyi E; Stanbridge EJ; Nelson DL; Chinault C; Heslop H; Gross TG; Seemayer TA; Klein G; Purtilo DT; Sumegi J
    Genomics; 1997 Jan; 39(1):55-65. PubMed ID: 9027486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP).
    Sanger WG; Grierson HL; Skare J; Wyandt H; Pirruccello S; Fordyce R; Purtilo DT
    Cancer Genet Cytogenet; 1990 Jul; 47(2):163-9. PubMed ID: 1972651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X linked lymphoproliferative disease in a United Kingdom family.
    Arkwright PD; Makin G; Will AM; Ayres M; Gokhale DA; Fergusson WD; Taylor GM
    Arch Dis Child; 1998 Jul; 79(1):52-5. PubMed ID: 9771253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Documentation of Burkitt lymphoma with t(8;14) (q24;q32) in X-linked lymphoproliferative disease.
    Egeler RM; de Kraker J; Slater R; Purtilo DT
    Cancer; 1992 Aug; 70(3):683-7. PubMed ID: 1623484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked lymphoproliferative syndrome.
    Sullivan JL; Woda BA
    Immunodefic Rev; 1989; 1(4):325-47. PubMed ID: 2561059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus and the X-linked lymphoproliferative syndrome.
    Sullivan JL
    Adv Pediatr; 1983; 30():365-99. PubMed ID: 6324556
    [No Abstract]   [Full Text] [Related]  

  • 13. [X chromosome-linked lymphoproliferative syndrome (Duncan's disease)].
    Král V; Jílek D; Pajerek J; Stasný J; Kofer J; Vávra M; Richter J
    Cas Lek Cesk; 1990 Feb; 129(8):247-51. PubMed ID: 2158858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical map and cosmid contig encompassing a new interstitial deletion of the X-linked lymphoproliferative syndrome region.
    Lamartine J; Nichols KE; Yin L; Krainer M; Heitzmann F; Bernard A; Gaudi S; Lenoir GM; Sullivan JL; Ikeda JE; Porta G; Schlessinger D; Romeo G; Haber DA; Sylla BS; Harkin DP
    Eur J Hum Genet; 1996; 4(6):342-51. PubMed ID: 9043868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).
    Grierson HL; Skare J; Church J; Silberman T; Davis JR; Kobrinsky N; McGregor R; Israels S; McCarty J; Andrews LG
    Am J Med Genet; 1993 Sep; 47(4):458-63. PubMed ID: 8256804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
    Purtilo DT
    Biomed Pharmacother; 1985; 39(2):52-8. PubMed ID: 2990590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome.
    Loeffel S; Chang CH; Heyn R; Harada S; Lipscomb H; Sinangil F; Volsky DJ; McClain K; Ochs H; Purtilo DT
    Arch Pathol Lab Med; 1985 Jun; 109(6):546-50. PubMed ID: 2986573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families.
    Schuster V; Dohrmann E; Kreth HW
    Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.